nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0982	0.216	CbGbCtD
Darifenacin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0744	0.164	CbGbCtD
Darifenacin—CYP3A4—Betamethasone—psoriatic arthritis	0.0639	0.14	CbGbCtD
Darifenacin—CYP3A4—Prednisolone—psoriatic arthritis	0.063	0.139	CbGbCtD
Darifenacin—CYP3A4—Prednisone—psoriatic arthritis	0.0595	0.131	CbGbCtD
Darifenacin—CYP2D6—Dexamethasone—psoriatic arthritis	0.0584	0.129	CbGbCtD
Darifenacin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0372	0.0817	CbGbCtD
Darifenacin—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00273	0.00501	CcSEcCtD
Darifenacin—Weight increased—Triamcinolone—psoriatic arthritis	0.00261	0.0048	CcSEcCtD
Darifenacin—Weight increased—Methylprednisolone—psoriatic arthritis	0.00261	0.00478	CcSEcCtD
Darifenacin—Infestation—Methylprednisolone—psoriatic arthritis	0.00256	0.00469	CcSEcCtD
Darifenacin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00256	0.00469	CcSEcCtD
Darifenacin—Face oedema—Prednisone—psoriatic arthritis	0.00254	0.00465	CcSEcCtD
Darifenacin—Sweating—Methylprednisolone—psoriatic arthritis	0.00245	0.00449	CcSEcCtD
Darifenacin—Visual impairment—Prednisolone—psoriatic arthritis	0.00241	0.00442	CcSEcCtD
Darifenacin—Dry skin—Prednisone—psoriatic arthritis	0.00241	0.00442	CcSEcCtD
Darifenacin—Weight increased—Dexamethasone—psoriatic arthritis	0.00237	0.00435	CcSEcCtD
Darifenacin—Weight increased—Betamethasone—psoriatic arthritis	0.00237	0.00435	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00232	0.00425	CcSEcCtD
Darifenacin—Visual disturbance—Methotrexate—psoriatic arthritis	0.00232	0.00425	CcSEcCtD
Darifenacin—Rhinitis—Triamcinolone—psoriatic arthritis	0.00231	0.00423	CcSEcCtD
Darifenacin—Rhinitis—Methylprednisolone—psoriatic arthritis	0.0023	0.00422	CcSEcCtD
Darifenacin—Hallucination—Methylprednisolone—psoriatic arthritis	0.00228	0.00419	CcSEcCtD
Darifenacin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00228	0.00419	CcSEcCtD
Darifenacin—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00224	0.00411	CcSEcCtD
Darifenacin—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00221	0.00406	CcSEcCtD
Darifenacin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00214	0.00393	CcSEcCtD
Darifenacin—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00209	0.00383	CcSEcCtD
Darifenacin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00208	0.00382	CcSEcCtD
Darifenacin—Hallucination—Dexamethasone—psoriatic arthritis	0.00208	0.00381	CcSEcCtD
Darifenacin—Hallucination—Betamethasone—psoriatic arthritis	0.00208	0.00381	CcSEcCtD
Darifenacin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00207	0.00379	CcSEcCtD
Darifenacin—Weight increased—Prednisone—psoriatic arthritis	0.00207	0.00379	CcSEcCtD
Darifenacin—Vision blurred—Prednisolone—psoriatic arthritis	0.00205	0.00376	CcSEcCtD
Darifenacin—Visual impairment—Dexamethasone—psoriatic arthritis	0.00201	0.00369	CcSEcCtD
Darifenacin—Visual impairment—Betamethasone—psoriatic arthritis	0.00201	0.00369	CcSEcCtD
Darifenacin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00201	0.00369	CcSEcCtD
Darifenacin—Angioedema—Prednisolone—psoriatic arthritis	0.00199	0.00365	CcSEcCtD
Darifenacin—Breast disorder—Methotrexate—psoriatic arthritis	0.00198	0.00364	CcSEcCtD
Darifenacin—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00196	0.0036	CcSEcCtD
Darifenacin—Syncope—Prednisolone—psoriatic arthritis	0.00195	0.00358	CcSEcCtD
Darifenacin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00195	0.00358	CcSEcCtD
Darifenacin—Eye disorder—Betamethasone—psoriatic arthritis	0.00195	0.00358	CcSEcCtD
Darifenacin—Back pain—Triamcinolone—psoriatic arthritis	0.00194	0.00355	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00191	0.00351	CcSEcCtD
Darifenacin—Angiopathy—Betamethasone—psoriatic arthritis	0.00189	0.00347	CcSEcCtD
Darifenacin—Angiopathy—Dexamethasone—psoriatic arthritis	0.00189	0.00347	CcSEcCtD
Darifenacin—Hypertension—Prednisolone—psoriatic arthritis	0.00188	0.00345	CcSEcCtD
Darifenacin—Angioedema—Triamcinolone—psoriatic arthritis	0.00183	0.00335	CcSEcCtD
Darifenacin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00183	0.00335	CcSEcCtD
Darifenacin—Hallucination—Prednisone—psoriatic arthritis	0.00181	0.00332	CcSEcCtD
Darifenacin—Syncope—Triamcinolone—psoriatic arthritis	0.0018	0.00329	CcSEcCtD
Darifenacin—Syncope—Methylprednisolone—psoriatic arthritis	0.00179	0.00329	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00178	0.00326	CcSEcCtD
Darifenacin—Oedema—Prednisolone—psoriatic arthritis	0.00178	0.00326	CcSEcCtD
Darifenacin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00176	0.00323	CcSEcCtD
Darifenacin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00176	0.00322	CcSEcCtD
Darifenacin—Shock—Prednisolone—psoriatic arthritis	0.00175	0.00321	CcSEcCtD
Darifenacin—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00175	0.0032	CcSEcCtD
Darifenacin—Cough—Triamcinolone—psoriatic arthritis	0.00175	0.0032	CcSEcCtD
Darifenacin—Tachycardia—Prednisolone—psoriatic arthritis	0.00173	0.00318	CcSEcCtD
Darifenacin—Hypertension—Triamcinolone—psoriatic arthritis	0.00173	0.00317	CcSEcCtD
Darifenacin—Hypertension—Methylprednisolone—psoriatic arthritis	0.00172	0.00316	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00172	0.00315	CcSEcCtD
Darifenacin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.0017	0.00312	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—psoriatic arthritis	0.0017	0.00311	CcSEcCtD
Darifenacin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00169	0.0031	CcSEcCtD
Darifenacin—Infestation—Methotrexate—psoriatic arthritis	0.00169	0.0031	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00169	0.0031	CcSEcCtD
Darifenacin—Dry mouth—Triamcinolone—psoriatic arthritis	0.00167	0.00306	CcSEcCtD
Darifenacin—Angioedema—Dexamethasone—psoriatic arthritis	0.00166	0.00304	CcSEcCtD
Darifenacin—Angioedema—Betamethasone—psoriatic arthritis	0.00166	0.00304	CcSEcCtD
Darifenacin—Stomatitis—Methotrexate—psoriatic arthritis	0.00165	0.00302	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—psoriatic arthritis	0.00165	0.00302	CcSEcCtD
Darifenacin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00164	0.00301	CcSEcCtD
Darifenacin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00163	0.003	CcSEcCtD
Darifenacin—Oedema—Triamcinolone—psoriatic arthritis	0.00163	0.003	CcSEcCtD
Darifenacin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00163	0.00299	CcSEcCtD
Darifenacin—Syncope—Dexamethasone—psoriatic arthritis	0.00163	0.00299	CcSEcCtD
Darifenacin—Syncope—Betamethasone—psoriatic arthritis	0.00163	0.00299	CcSEcCtD
Darifenacin—Infection—Triamcinolone—psoriatic arthritis	0.00162	0.00298	CcSEcCtD
Darifenacin—Sweating—Methotrexate—psoriatic arthritis	0.00162	0.00297	CcSEcCtD
Darifenacin—Infection—Methylprednisolone—psoriatic arthritis	0.00162	0.00297	CcSEcCtD
Darifenacin—Shock—Triamcinolone—psoriatic arthritis	0.00161	0.00295	CcSEcCtD
Darifenacin—Insomnia—Prednisolone—psoriatic arthritis	0.00161	0.00295	CcSEcCtD
Darifenacin—Shock—Methylprednisolone—psoriatic arthritis	0.0016	0.00294	CcSEcCtD
Darifenacin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0016	0.00293	CcSEcCtD
Darifenacin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.0016	0.00293	CcSEcCtD
Darifenacin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.0016	0.00293	CcSEcCtD
Darifenacin—Tachycardia—Triamcinolone—psoriatic arthritis	0.00159	0.00292	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—psoriatic arthritis	0.00159	0.00292	CcSEcCtD
Darifenacin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00159	0.00292	CcSEcCtD
Darifenacin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00158	0.0029	CcSEcCtD
Darifenacin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00158	0.0029	CcSEcCtD
Darifenacin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00158	0.00289	CcSEcCtD
Darifenacin—Hypertension—Betamethasone—psoriatic arthritis	0.00157	0.00288	CcSEcCtD
Darifenacin—Hypertension—Dexamethasone—psoriatic arthritis	0.00157	0.00288	CcSEcCtD
Darifenacin—Pain—Prednisolone—psoriatic arthritis	0.00152	0.00279	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—psoriatic arthritis	0.00151	0.00276	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.0015	0.00275	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—psoriatic arthritis	0.00149	0.00273	CcSEcCtD
Darifenacin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00149	0.00273	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00149	0.00273	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00149	0.00272	CcSEcCtD
Darifenacin—Oedema—Betamethasone—psoriatic arthritis	0.00148	0.00272	CcSEcCtD
Darifenacin—Oedema—Dexamethasone—psoriatic arthritis	0.00148	0.00272	CcSEcCtD
Darifenacin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00148	0.00272	CcSEcCtD
Darifenacin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00148	0.00272	CcSEcCtD
Darifenacin—Insomnia—Triamcinolone—psoriatic arthritis	0.00148	0.00271	CcSEcCtD
Darifenacin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00147	0.0027	CcSEcCtD
Darifenacin—Infection—Betamethasone—psoriatic arthritis	0.00147	0.0027	CcSEcCtD
Darifenacin—Infection—Dexamethasone—psoriatic arthritis	0.00147	0.0027	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00146	0.00268	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—psoriatic arthritis	0.00146	0.00268	CcSEcCtD
Darifenacin—Shock—Dexamethasone—psoriatic arthritis	0.00146	0.00267	CcSEcCtD
Darifenacin—Shock—Betamethasone—psoriatic arthritis	0.00146	0.00267	CcSEcCtD
Darifenacin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00146	0.00267	CcSEcCtD
Darifenacin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00145	0.00267	CcSEcCtD
Darifenacin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00145	0.00267	CcSEcCtD
Darifenacin—Tachycardia—Betamethasone—psoriatic arthritis	0.00145	0.00265	CcSEcCtD
Darifenacin—Tachycardia—Dexamethasone—psoriatic arthritis	0.00145	0.00265	CcSEcCtD
Darifenacin—Angioedema—Prednisone—psoriatic arthritis	0.00145	0.00265	CcSEcCtD
Darifenacin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00144	0.00264	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00144	0.00263	CcSEcCtD
Darifenacin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00144	0.00263	CcSEcCtD
Darifenacin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00143	0.00263	CcSEcCtD
Darifenacin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00143	0.00263	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—psoriatic arthritis	0.00142	0.0026	CcSEcCtD
Darifenacin—Syncope—Prednisone—psoriatic arthritis	0.00142	0.0026	CcSEcCtD
Darifenacin—Pain—Triamcinolone—psoriatic arthritis	0.0014	0.00256	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—psoriatic arthritis	0.00139	0.00255	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—psoriatic arthritis	0.00138	0.00253	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00137	0.00251	CcSEcCtD
Darifenacin—Hypertension—Prednisone—psoriatic arthritis	0.00137	0.0025	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00135	0.00248	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00135	0.00248	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—psoriatic arthritis	0.00135	0.00247	CcSEcCtD
Darifenacin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00135	0.00247	CcSEcCtD
Darifenacin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00134	0.00246	CcSEcCtD
Darifenacin—Insomnia—Betamethasone—psoriatic arthritis	0.00134	0.00246	CcSEcCtD
Darifenacin—Insomnia—Dexamethasone—psoriatic arthritis	0.00134	0.00246	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00134	0.00245	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00133	0.00244	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—psoriatic arthritis	0.00133	0.00244	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00131	0.0024	CcSEcCtD
Darifenacin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00131	0.00239	CcSEcCtD
Darifenacin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00131	0.00239	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—psoriatic arthritis	0.00129	0.00237	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00129	0.00237	CcSEcCtD
Darifenacin—Oedema—Prednisone—psoriatic arthritis	0.00129	0.00237	CcSEcCtD
Darifenacin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00129	0.00236	CcSEcCtD
Darifenacin—Infection—Prednisone—psoriatic arthritis	0.00128	0.00235	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00128	0.00235	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00128	0.00235	CcSEcCtD
Darifenacin—Back pain—Methotrexate—psoriatic arthritis	0.00128	0.00235	CcSEcCtD
Darifenacin—Shock—Prednisone—psoriatic arthritis	0.00127	0.00233	CcSEcCtD
Darifenacin—Pain—Dexamethasone—psoriatic arthritis	0.00127	0.00232	CcSEcCtD
Darifenacin—Pain—Betamethasone—psoriatic arthritis	0.00127	0.00232	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00127	0.00232	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—psoriatic arthritis	0.00126	0.00231	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—psoriatic arthritis	0.00125	0.0023	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00125	0.00229	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—psoriatic arthritis	0.00125	0.00228	CcSEcCtD
Darifenacin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00122	0.00224	CcSEcCtD
Darifenacin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00122	0.00224	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00121	0.00222	CcSEcCtD
Darifenacin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00121	0.00222	CcSEcCtD
Darifenacin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0012	0.00221	CcSEcCtD
Darifenacin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.0012	0.0022	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00118	0.00216	CcSEcCtD
Darifenacin—Dizziness—Prednisolone—psoriatic arthritis	0.00117	0.00215	CcSEcCtD
Darifenacin—Asthenia—Triamcinolone—psoriatic arthritis	0.00117	0.00215	CcSEcCtD
Darifenacin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00117	0.00215	CcSEcCtD
Darifenacin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00117	0.00215	CcSEcCtD
Darifenacin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00117	0.00214	CcSEcCtD
Darifenacin—Insomnia—Prednisone—psoriatic arthritis	0.00117	0.00214	CcSEcCtD
Darifenacin—Pruritus—Triamcinolone—psoriatic arthritis	0.00116	0.00212	CcSEcCtD
Darifenacin—Cough—Methotrexate—psoriatic arthritis	0.00115	0.00212	CcSEcCtD
Darifenacin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00115	0.00212	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—psoriatic arthritis	0.00114	0.00208	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—psoriatic arthritis	0.00113	0.00206	CcSEcCtD
Darifenacin—Rash—Prednisolone—psoriatic arthritis	0.00112	0.00205	CcSEcCtD
Darifenacin—Dermatitis—Prednisolone—psoriatic arthritis	0.00112	0.00205	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00112	0.00205	CcSEcCtD
Darifenacin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00112	0.00205	CcSEcCtD
Darifenacin—Headache—Prednisolone—psoriatic arthritis	0.00111	0.00204	CcSEcCtD
Darifenacin—Constipation—Prednisone—psoriatic arthritis	0.0011	0.00202	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—psoriatic arthritis	0.00109	0.002	CcSEcCtD
Darifenacin—Dizziness—Triamcinolone—psoriatic arthritis	0.00108	0.00198	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00108	0.00198	CcSEcCtD
Darifenacin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00108	0.00198	CcSEcCtD
Darifenacin—Infection—Methotrexate—psoriatic arthritis	0.00107	0.00197	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00106	0.00195	CcSEcCtD
Darifenacin—Asthenia—Dexamethasone—psoriatic arthritis	0.00106	0.00195	CcSEcCtD
Darifenacin—Asthenia—Betamethasone—psoriatic arthritis	0.00106	0.00195	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00106	0.00194	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00106	0.00194	CcSEcCtD
Darifenacin—Nausea—Prednisolone—psoriatic arthritis	0.00106	0.00194	CcSEcCtD
Darifenacin—Pruritus—Dexamethasone—psoriatic arthritis	0.00105	0.00192	CcSEcCtD
Darifenacin—Pruritus—Betamethasone—psoriatic arthritis	0.00105	0.00192	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—psoriatic arthritis	0.00105	0.00192	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00104	0.00191	CcSEcCtD
Darifenacin—Vomiting—Triamcinolone—psoriatic arthritis	0.00104	0.00191	CcSEcCtD
Darifenacin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00104	0.0019	CcSEcCtD
Darifenacin—Rash—Triamcinolone—psoriatic arthritis	0.00103	0.00189	CcSEcCtD
Darifenacin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00103	0.00189	CcSEcCtD
Darifenacin—Rash—Methylprednisolone—psoriatic arthritis	0.00103	0.00189	CcSEcCtD
Darifenacin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00103	0.00188	CcSEcCtD
Darifenacin—Headache—Triamcinolone—psoriatic arthritis	0.00102	0.00188	CcSEcCtD
Darifenacin—Headache—Methylprednisolone—psoriatic arthritis	0.00102	0.00187	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—psoriatic arthritis	0.00102	0.00187	CcSEcCtD
Darifenacin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00101	0.00186	CcSEcCtD
Darifenacin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00101	0.00186	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000983	0.0018	CcSEcCtD
Darifenacin—Dizziness—Betamethasone—psoriatic arthritis	0.00098	0.0018	CcSEcCtD
Darifenacin—Dizziness—Dexamethasone—psoriatic arthritis	0.00098	0.0018	CcSEcCtD
Darifenacin—Insomnia—Methotrexate—psoriatic arthritis	0.000976	0.00179	CcSEcCtD
Darifenacin—Nausea—Triamcinolone—psoriatic arthritis	0.000971	0.00178	CcSEcCtD
Darifenacin—Nausea—Methylprednisolone—psoriatic arthritis	0.000968	0.00178	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000962	0.00176	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—psoriatic arthritis	0.000959	0.00176	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000951	0.00174	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—psoriatic arthritis	0.00095	0.00174	CcSEcCtD
Darifenacin—Vomiting—Dexamethasone—psoriatic arthritis	0.000943	0.00173	CcSEcCtD
Darifenacin—Vomiting—Betamethasone—psoriatic arthritis	0.000943	0.00173	CcSEcCtD
Darifenacin—Rash—Betamethasone—psoriatic arthritis	0.000935	0.00171	CcSEcCtD
Darifenacin—Rash—Dexamethasone—psoriatic arthritis	0.000935	0.00171	CcSEcCtD
Darifenacin—Dermatitis—Betamethasone—psoriatic arthritis	0.000934	0.00171	CcSEcCtD
Darifenacin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000934	0.00171	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000932	0.00171	CcSEcCtD
Darifenacin—Headache—Dexamethasone—psoriatic arthritis	0.000929	0.0017	CcSEcCtD
Darifenacin—Headache—Betamethasone—psoriatic arthritis	0.000929	0.0017	CcSEcCtD
Darifenacin—Asthenia—Prednisone—psoriatic arthritis	0.000926	0.0017	CcSEcCtD
Darifenacin—Pain—Methotrexate—psoriatic arthritis	0.000923	0.00169	CcSEcCtD
Darifenacin—Pruritus—Prednisone—psoriatic arthritis	0.000913	0.00168	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000889	0.00163	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—psoriatic arthritis	0.000883	0.00162	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000882	0.00162	CcSEcCtD
Darifenacin—Nausea—Dexamethasone—psoriatic arthritis	0.000881	0.00161	CcSEcCtD
Darifenacin—Nausea—Betamethasone—psoriatic arthritis	0.000881	0.00161	CcSEcCtD
Darifenacin—Dizziness—Prednisone—psoriatic arthritis	0.000854	0.00157	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000853	0.00156	CcSEcCtD
Darifenacin—Vomiting—Prednisone—psoriatic arthritis	0.000821	0.00151	CcSEcCtD
Darifenacin—Rash—Prednisone—psoriatic arthritis	0.000814	0.00149	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—psoriatic arthritis	0.000813	0.00149	CcSEcCtD
Darifenacin—Headache—Prednisone—psoriatic arthritis	0.000809	0.00148	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000795	0.00146	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—psoriatic arthritis	0.000774	0.00142	CcSEcCtD
Darifenacin—Nausea—Prednisone—psoriatic arthritis	0.000767	0.00141	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—psoriatic arthritis	0.000763	0.0014	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000738	0.00135	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—psoriatic arthritis	0.000714	0.00131	CcSEcCtD
Darifenacin—Vomiting—Methotrexate—psoriatic arthritis	0.000686	0.00126	CcSEcCtD
Darifenacin—Rash—Methotrexate—psoriatic arthritis	0.00068	0.00125	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—psoriatic arthritis	0.00068	0.00125	CcSEcCtD
Darifenacin—Headache—Methotrexate—psoriatic arthritis	0.000676	0.00124	CcSEcCtD
Darifenacin—Nausea—Methotrexate—psoriatic arthritis	0.000641	0.00118	CcSEcCtD
